Mutant IDH1: An immunotherapeutic target in tumors.
- Published in:
- OncoImmunology, 2014, v. 3, n. 12, p. N.PAG, doi. 10.4161/2162402X.2014.974392
- By:
- Publication type:
- Article
Works in OncoImmunology, 2014, Vol 3, Issue 12
Results: 14
1
2
Roadblocks to success for RNA CARs in solid tumors.
- Published in:
- OncoImmunology, 2014, v. 3, n. 12, p. N.PAG, doi. 10.4161/21624011.2014.962974
- By:
- Publication type:
- Article
3
Heteroclitic XBP1 peptides evoke tumor-specific memory cytotoxic T lymphocytes against breast cancer, colon cancer, and pancreatic cancer cells.
- Published in:
- OncoImmunology, 2014, v. 3, n. 12, p. N.PAG, doi. 10.4161/21624011.2014.970914
- By:
- Publication type:
- Article
4
Quantitative T cell repertoire analysis by deep cDNA sequencing of T cell receptor α and β chains using next-generation sequencing (NGS).
- Published in:
- OncoImmunology, 2014, v. 3, n. 12, p. N.PAG, doi. 10.4161/21624011.2014.968467
- By:
- Publication type:
- Article
5
Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy.
- Published in:
- OncoImmunology, 2014, v. 3, n. 12, p. N.PAG, doi. 10.4161/21624011.2014.968434
- By:
- Publication type:
- Article
6
Neoadjuvant immunotherapy with chitosan and interleukin-12 to control breast cancer metastasis.
- Published in:
- OncoImmunology, 2014, v. 3, n. 12, p. N.PAG, doi. 10.4161/21624011.2014.968001
- By:
- Publication type:
- Article
7
Sperm associated antigen 9 ( SPAG9 ) expression and humoral response in benign and malignant salivary gland tumors.
- Published in:
- OncoImmunology, 2014, v. 3, n. 12, p. N.PAG, doi. 10.4161/2162402X.2014.974382
- By:
- Publication type:
- Article
8
Interleukin-6 receptor and its ligand interleukin-6 are opposite markers for survival and infiltration with mature myeloid cells in ovarian cancer.
- Published in:
- OncoImmunology, 2014, v. 3, n. 12, p. N.PAG, doi. 10.4161/21624011.2014.962397
- By:
- Publication type:
- Article
9
Atypical chemokine receptor 2: a brake against Kaposi's sarcoma aggressiveness.
- Published in:
- OncoImmunology, 2014, v. 3, n. 12, p. N.PAG, doi. 10.4161/21624011.2014.955337
- By:
- Publication type:
- Article
10
Subverting the adaptive immune resistance mechanism to improve clinical responses to immune checkpoint blockade therapy.
- Published in:
- OncoImmunology, 2014, v. 3, n. 12, p. N.PAG, doi. 10.4161/21624011.2014.954868
- By:
- Publication type:
- Article
11
Tumor-expressed IL-17D recruits NK cells to reject tumors.
- Published in:
- OncoImmunology, 2014, v. 3, n. 12, p. N.PAG, doi. 10.4161/21624011.2014.954853
- By:
- Publication type:
- Article
12
Targeting hypoxia at the forefront of anticancer immune responses.
- Published in:
- OncoImmunology, 2014, v. 3, n. 12, p. N.PAG, doi. 10.4161/21624011.2014.954463
- By:
- Publication type:
- Article
13
Reversal of natural killer cell exhaustion by TIM-3 blockade.
- Published in:
- OncoImmunology, 2014, v. 3, n. 12, p. N.PAG, doi. 10.4161/21624011.2014.946365
- By:
- Publication type:
- Article
14
Class II-associated invariant chain peptide as predictive immune marker in minimal residual disease in acute myeloid leukemia.
- Published in:
- OncoImmunology, 2014, v. 3, n. 12, p. N.PAG, doi. 10.4161/21624011.2014.941737
- By:
- Publication type:
- Article